Pfizer Says Covid Vaccine Is More Than 90% Effective—’ Great Day For Science And Humanity’
This Monday, Pfizer and BioNTech announced their coronavirus vaccine was more than 90% effective in preventing Covid-19, hailing the development as “a great day for science and humanity.”
RELATED: Johnson & Johnson Pauses Covid-19 Vaccine Trial After ‘Unexplained Illness’
Following their Phase 3 study of the vaccine where 94 of the trial’s 43,538 participants contracted COVID-19, an analysis showed the vaccine was more than 90 percent effective seven days after patients received the second of two doses, meaning they become protected from the virus 28 days after starting the vaccination course, according to the New York Post citing companies.
They have so far found no serious safety concerns and added that it hopes to have the amount of safety data required for a Food and Drug Administration (FDA) Emergency Use Authorization by the third week of November for people aged 16 to 85.
“Today is a great day for science and humanity,” Albert Bourla, Pfizer’s chairman and chief executive said in a statement. “We are reaching this critical milestone in our vaccine development program at a time when the world needs it most with infection rates setting new records, hospitals nearing over-capacity, and economies struggling to reopen.”
Press Play Below For More:
RELATED: President Trump Claims CDC Director Is Wrong About Masks And Vaccines